CCT5 Antibody

What is CCT5 and what is its biological function?

CCT5, also known as TCP1 epsilon, is a subunit of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists in the folding of proteins through ATP hydrolysis. This complex plays a crucial role in cellular proteostasis by ensuring proper protein folding. CCT5 functions as part of the TRiC complex to mediate the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. Additionally, the TRiC complex containing CCT5 may play a role in the assembly of the BBSome, a complex involved in ciliogenesis and vesicle transport to cilia . CCT5 is particularly important for the folding of cytoskeletal proteins such as actin and tubulin, which are essential for maintaining cellular structure and function .

The protein is primarily localized in the cytoplasm, cytoskeleton, and centrosome, reflecting its involvement in cytoskeletal organization and cell division processes . Understanding CCT5's biological functions provides context for researchers designing experiments to investigate its roles in normal cellular processes and potential dysregulation in disease states.

What types of CCT5 antibodies are commercially available for research?

Most commercially available CCT5 antibodies are rabbit polyclonal antibodies that target specific regions of the human CCT5 protein. These antibodies are typically generated using recombinant fragments or fusion proteins of human CCT5. For example, some antibodies are raised against recombinant fragments corresponding to amino acids 50-350 of human CCT5 , while others may use fusion proteins of human CCT5 as immunogens .

The antibodies undergo affinity purification to enhance specificity and reduce background noise in experimental applications . Most are provided in buffer solutions containing stabilizers such as glycerol to maintain antibody integrity during storage. For instance, some preparations contain phosphate buffered solution (pH 7.4) with 0.05% stabilizer and 50% glycerol , while others may use PBS (pH 7.2) with 40% glycerol and 0.02% sodium azide .

What are the validated applications for CCT5 antibodies?

CCT5 antibodies have been validated for several common laboratory applications, with performance varying by manufacturer. The most commonly validated applications include:

• Western Blot (WB): Typically used at dilutions ranging from 0.4 μg/ml to 1/1000, depending on the specific antibody .

• Immunohistochemistry (IHC): Both paraffin-embedded (IHC-P) and frozen section protocols are supported, with recommended dilutions ranging from 1:20 to 1:300 .

• Immunocytochemistry/Immunofluorescence (ICC/IF): Effective at concentrations of approximately 1-4 μg/ml, allowing for cellular localization studies .

When selecting an antibody for a specific application, researchers should carefully review the validation data provided by manufacturers and consider published literature where these antibodies have been successfully employed. Some antibodies have been used in peer-reviewed publications, which can provide additional confidence in their performance for specific applications .

What species reactivity can be expected from CCT5 antibodies?

Most commercially available CCT5 antibodies demonstrate reactivity with human, mouse, and rat samples . This cross-species reactivity is due to the high conservation of the CCT5 protein sequence across mammals. The specificity for these species has been verified through various validation methods, including western blot analysis, immunohistochemistry, and immunocytochemistry.

When working with samples from species other than human, mouse, or rat, researchers should exercise caution as the reactivity may not be guaranteed. Some manufacturers indicate that antibodies may work with other species based on sequence homology, but these predictions are not always verified experimentally . For critical experiments involving non-validated species, preliminary testing or selection of antibodies specifically validated for the target species is recommended.

How should CCT5 antibodies be stored and handled?

Proper storage and handling of CCT5 antibodies are crucial for maintaining their performance and extending their shelf life. Based on manufacturer recommendations, researchers should:

• Store antibodies at -20°C for long-term storage. Some products remain viable for up to 12 months when stored properly .

• For short-term storage (less than one month), antibodies can be kept at 4°C .

• Avoid repeated freeze-thaw cycles, as these can degrade antibody quality and performance. Aliquoting antibodies upon receipt is recommended if multiple uses are anticipated .

• When shipping is required, antibodies are typically transported with ice packs. Upon receipt, they should be immediately stored at the recommended temperature .

• Most antibodies are provided in buffer solutions containing glycerol (typically 40-50%) and stabilizers, which help prevent freezing damage and maintain antibody integrity .

Following these storage and handling guidelines will help ensure consistent experimental results and maximize the usable lifetime of the antibody reagents.

How does the TRiC complex containing CCT5 affect protein folding mechanisms?

The TRiC complex (also known as CCT) functions as a molecular machine that facilitates the proper folding of approximately 10% of the cellular proteome. CCT5, as one of the eight subunits of this complex, contributes to its ATP-dependent folding activity. The TRiC complex forms a characteristic double-ring structure composed of two identical stacked rings, each containing eight different proteins including CCT5 . This barrel-shaped structure creates a central cavity where unfolded polypeptides enter and undergo conformational changes leading to their proper three-dimensional structure.

The protein folding mechanism involves several steps: 1) recognition and binding of unfolded or partially folded substrate proteins, 2) ATP-dependent conformational changes in the complex that facilitate substrate folding, and 3) release of the properly folded protein . CCT5 participates in these processes through its ATPase activity and substrate-binding capabilities.

Research suggests that the TRiC complex has particular importance for folding proteins with complex topologies that are prone to aggregation, including cytoskeletal proteins like actin and tubulin . Additionally, the complex plays a role in folding proteins involved in cell cycle regulation, signal transduction, and chromatin remodeling. The specificity of TRiC for certain substrates is partly determined by the unique properties of each subunit, including CCT5, which contributes to the recognition and processing of specific client proteins.

What considerations are important for validating CCT5 antibody specificity?

Validating CCT5 antibody specificity is essential for obtaining reliable experimental results. Researchers should consider several approaches to confirm antibody specificity:

• Protein array validation: Some manufacturers validate specificity by testing antibodies against arrays containing the target protein plus numerous non-specific proteins. For example, certain CCT5 antibodies have been verified against arrays containing the target protein plus 383 other non-specific proteins .

• Multiple detection methods: Confirming CCT5 detection using different techniques (e.g., western blot, immunohistochemistry, and immunofluorescence) provides stronger evidence of specificity.

• Positive and negative controls: Using tissues or cell lines with known CCT5 expression levels as positive controls, and comparing with CCT5-deficient samples or knockout models as negative controls.

• Peptide competition assays: Pre-incubating the antibody with its specific immunogenic peptide should abolish specific staining in your experimental system.

• Multiple antibody validation: Using different antibodies targeting distinct epitopes of CCT5 can provide complementary evidence of specificity when they yield consistent results.

• Molecular weight verification: Confirming that the detected protein has the expected molecular weight for CCT5 (approximately 60 kDa) in western blot applications.

• Subcellular localization pattern: Verifying that the staining pattern matches the expected cytoplasmic, cytoskeletal, and centrosomal localization of CCT5 .

These validation steps help ensure that experimental observations truly reflect CCT5 biology rather than non-specific interactions or artifacts.

What are the optimal experimental conditions for different CCT5 antibody applications?

Optimizing experimental conditions for CCT5 antibody applications requires attention to several parameters:

For Western Blot (WB):

• Sample preparation: Effective lysis buffers typically contain detergents suitable for cytoplasmic proteins.

• Loading concentration: 10-30 μg of total protein per lane is typically sufficient.

• Antibody dilution: Ranges from 0.4 μg/ml to 1/1000 depending on the specific antibody .

• Detection system: Both chemiluminescence and fluorescence-based systems are suitable.

• Expected band: CCT5 appears at approximately 60 kDa on SDS-PAGE gels .

For Immunohistochemistry (IHC):

• Fixation: Formalin-fixed, paraffin-embedded tissues work well with most CCT5 antibodies.

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) is commonly effective.

• Antibody dilution: Recommended ranges vary from 1:20 to 1:300 depending on the specific antibody and detection system .

• Incubation conditions: Overnight incubation at 4°C often provides optimal staining with minimal background.

• Verified tissues: Human tonsil has been verified as a positive control for some CCT5 antibodies .

For Immunocytochemistry/Immunofluorescence (ICC/IF):

• Fixation: 4% paraformaldehyde for 15-20 minutes at room temperature preserves cellular architecture.

• Permeabilization: 0.1-0.5% Triton X-100 for cytoplasmic proteins like CCT5.

• Blocking: 5-10% normal serum from the same species as the secondary antibody.

• Antibody concentration: 1-4 μg/ml is typically effective .

• Counterstains: DAPI for nuclei and phalloidin for actin filaments can provide useful context for CCT5 localization.

These parameters serve as starting points and may require optimization for specific experimental systems and antibodies.

How can researchers troubleshoot inconsistent results with CCT5 antibodies?

When facing inconsistent results with CCT5 antibodies, researchers should systematically evaluate and adjust several aspects of their experimental protocol:

• Sample preparation issues:

  • Ensure complete protein denaturation for western blot applications.

  • Verify that fixation conditions preserve CCT5 epitopes.

  • Check for protein degradation by adding protease inhibitors to extraction buffers.

• Antibody-related factors:

  • Test different antibody lots, as lot-to-lot variation can occur.

  • Titrate antibody concentrations to identify optimal working dilutions.

  • Ensure proper antibody storage to prevent degradation.

  • Consider using alternative antibodies targeting different epitopes of CCT5.

• Technical parameters:

  • For IHC/ICC, optimize antigen retrieval methods and incubation times.

  • For western blot, adjust transfer conditions, especially for higher molecular weight proteins.

  • Evaluate blocking reagents to minimize non-specific binding.

  • Test different detection systems that may offer improved sensitivity or lower background.

• Biological variables:

  • Consider cell-type specific expression levels of CCT5.

  • Account for potential post-translational modifications affecting epitope recognition.

  • Evaluate whether experimental treatments might alter CCT5 expression or localization.

• Controls:

  • Always include positive controls (tissues/cells known to express CCT5).

  • Use negative controls (secondary antibody only, isotype controls).

  • Consider using siRNA knockdown or CRISPR knockout of CCT5 as definitive specificity controls.

Maintaining detailed laboratory records of experimental conditions and results facilitates systematic troubleshooting and protocol optimization.

What is the role of CCT5 in cytoskeletal organization and centrosome function?

CCT5, as part of the TRiC chaperonin complex, plays a crucial role in cytoskeletal organization primarily through its involvement in the folding of actin and tubulin, the major components of microfilaments and microtubules, respectively . Proper folding of these proteins is essential for cytoskeletal integrity and dynamics.

The localization of CCT5 to the centrosome suggests its importance in centrosome function and cell division processes. The centrosome serves as the primary microtubule organizing center in animal cells and is critical for mitotic spindle formation during cell division. CCT5's presence at this location indicates its role in:

• Facilitating the folding of centrosomal proteins necessary for centrosome duplication and maturation.

• Supporting the assembly of gamma-tubulin ring complexes that nucleate microtubules at the centrosome.

• Contributing to the regulation of microtubule dynamics during interphase and mitosis.

• Potentially participating in ciliogenesis, as suggested by its role in BBSome assembly .

Disruptions in CCT5 function could lead to cytoskeletal abnormalities and centrosome dysfunction, potentially resulting in mitotic defects, aberrant cell migration, and impaired ciliary formation. These cellular phenotypes are associated with various human diseases, including cancer and ciliopathies.

Research approaches to study CCT5's role in these processes include immunofluorescence microscopy to visualize co-localization with cytoskeletal and centrosomal markers, live-cell imaging to track dynamic processes, and functional assays measuring microtubule nucleation and stability following CCT5 perturbation.

What advanced techniques can be used to study CCT5 interactions with client proteins?

Several advanced techniques can elucidate CCT5's interactions with client proteins and its role within the TRiC complex:

• Proximity-based protein interaction assays:

  • BioID or TurboID approaches, where CCT5 is fused to a biotin ligase to biotinylate proximal proteins

  • APEX2 proximity labeling for electron microscopy visualization of interaction partners

  • FRET/BRET assays to measure direct protein-protein interactions in living cells

• Crosslinking mass spectrometry (XL-MS):

  • Chemical crosslinking of CCT5 with its binding partners followed by mass spectrometry

  • This approach can identify interaction interfaces and structural arrangements within the TRiC complex

• Cryo-electron microscopy (cryo-EM):

  • Visualization of TRiC complex architecture with bound substrate proteins

  • Structural analysis of conformational changes during the ATP hydrolysis cycle

• Single-molecule techniques:

  • Optical tweezers or atomic force microscopy to study the mechanical properties of CCT5-substrate interactions

  • Single-molecule FRET to monitor conformational changes during protein folding

• Protein folding assays:

  • In vitro reconstitution of the TRiC complex with purified components including CCT5

  • Real-time folding assays using fluorescent substrate proteins

  • Thermal shift assays to assess substrate stability

• Advanced microscopy techniques:

  • Super-resolution microscopy (STORM, PALM, SIM) to visualize CCT5 distribution at nanometer resolution

  • Live-cell imaging with fluorescently tagged CCT5 and substrate proteins

• Computational approaches:

  • Molecular dynamics simulations of CCT5-substrate interactions

  • AlphaFold or RoseTTAFold prediction of interaction interfaces

These advanced techniques can provide comprehensive insights into CCT5's functional interactions and its role in protein folding mechanisms beyond what can be achieved with standard antibody-based detection methods alone.

How can CCT5 antibodies be used in multiplex immunostaining protocols?

Multiplex immunostaining with CCT5 antibodies enables simultaneous visualization of CCT5 alongside other proteins of interest, providing contextual information about protein co-localization and cellular pathways. Successful multiplex protocols with CCT5 antibodies require careful planning and optimization:

• Antibody compatibility considerations:

  • Select primary antibodies raised in different host species to avoid cross-reactivity

  • If using multiple rabbit antibodies (as many CCT5 antibodies are rabbit-derived ), employ sequential staining with direct labeling or Zenon technology

  • Verify that fixation and antigen retrieval conditions are compatible for all target proteins

• Fluorophore selection strategies:

  • Choose fluorophores with minimal spectral overlap

  • Consider brightness matching based on target abundance (brighter fluorophores for less abundant proteins)

  • Account for tissue autofluorescence when selecting fluorophore excitation/emission spectra

• Sequential staining approach:

  • Begin with the least sensitive antibody (typically CCT5 antibodies are robust)

  • Between antibody applications, use elution buffers or heat treatment to remove previous antibodies

  • Validate that each elution step doesn't affect subsequent antigen detection

• Recommended combinations for CCT5 studies:

  • CCT5 + other TRiC complex components to study complex assembly

  • CCT5 + cytoskeletal markers (tubulin, actin) to examine chaperone-substrate relationships

  • CCT5 + centrosomal markers to investigate centrosome localization and function

• Validation and controls:

  • Single-stain controls to establish proper signal and lack of bleed-through

  • Fluorescence minus one (FMO) controls to set accurate thresholds

  • Absorption controls to confirm absence of secondary antibody cross-reactivity

• Image acquisition considerations:

  • Sequential scanning to minimize channel bleed-through

  • Consistent exposure settings for comparative analyses

  • Z-stack imaging to capture the full cellular distribution of CCT5

With careful optimization, multiplex immunostaining can provide valuable insights into CCT5's functional relationships with other proteins in various cellular contexts and pathological conditions.

What are the potential implications of CCT5 dysfunction in disease models?

Dysregulation of CCT5 and the TRiC complex has been implicated in several pathological conditions. Understanding these associations opens avenues for therapeutic interventions and biomarker development:

• Neurodegenerative disorders:

  • TRiC complex components, including CCT5, play protective roles against protein aggregation in neurodegenerative diseases such as Huntington's disease and Alzheimer's disease.

  • CCT5 assists in preventing the aggregation of proteins with expanded polyglutamine tracts.

  • Antibody-based studies of CCT5 expression and localization in neural tissues can provide insights into disease progression mechanisms.

• Cancer biology:

  • Altered expression of CCT5 has been observed in various cancer types.

  • The TRiC complex may support cancer cell proliferation by facilitating the folding of proteins involved in cell cycle regulation and signal transduction.

  • CCT5 antibodies can be used to assess expression levels in tumor samples, potentially correlating with prognosis or treatment response.

• Ciliopathies:

  • Given TRiC's role in BBSome assembly and ciliogenesis , CCT5 dysfunction may contribute to ciliopathies - disorders resulting from abnormal ciliary function.

  • CCT5 antibodies can help evaluate its expression and localization in primary cilia across different tissues.

• Stress response:

  • As a chaperone component, CCT5 may play roles in cellular stress responses, including heat shock and oxidative stress.

  • Immunostaining for CCT5 in stress models can reveal changes in expression or localization patterns.

• Developmental disorders:

  • Given the importance of cytoskeletal organization in development, CCT5 dysfunction might impact embryogenesis and tissue morphogenesis.

  • Developmental expression patterns can be tracked using stage-specific immunostaining with CCT5 antibodies.

Research using CCT5 antibodies in these disease contexts can help establish connections between chaperone dysfunction and pathological mechanisms, potentially identifying new therapeutic targets.

How can researchers quantify CCT5 expression levels across different experimental conditions?

Accurate quantification of CCT5 expression is essential for comparative studies across experimental conditions or disease states. Several methodological approaches using CCT5 antibodies can provide robust quantitative data:

• Western blot quantification:

  • Ensure linear range detection by running standard curves with known protein amounts

  • Use housekeeping proteins appropriate for your experimental condition as loading controls

  • Employ fluorescence-based secondary antibodies for wider linear range than chemiluminescence

  • Use densitometry software with background subtraction for band intensity analysis

  • Report results as normalized ratios (CCT5/loading control) for inter-blot comparisons

• Immunohistochemistry/immunofluorescence quantification:

  • Standardize all staining parameters (fixation time, antibody concentration, incubation periods)

  • Use automated image analysis software to quantify staining intensity

  • Measure both intensity and distribution parameters (e.g., H-score = % positive cells × intensity)

  • Include calibration standards on each slide for normalization

  • Consider tissue microarrays for high-throughput analysis across multiple samples

• Flow cytometry applications:

  • Optimize fixation and permeabilization for intracellular CCT5 staining

  • Use fluorescence minus one (FMO) controls to set gates accurately

  • Report median fluorescence intensity (MFI) rather than percent positive cells

  • Include quantitative beads to convert arbitrary units to molecules of equivalent soluble fluorochrome (MESF)

• ELISA-based quantification:

  • Develop sandwich ELISA using CCT5 antibodies recognizing different epitopes

  • Generate standard curves using recombinant CCT5 protein

  • Validate assay for linearity, precision, and recovery

  • Report absolute quantities in ng/ml or ng/mg total protein

• Multiplex protein assays:

  • Include CCT5 in multiplex bead-based assays alongside other proteins of interest

  • Validate for potential antibody cross-reactivity in the multiplex format

  • Use appropriate software for multi-parameter data analysis

Each method has advantages and limitations for CCT5 quantification. Selection should be based on the specific research question, sample availability, and required sensitivity/specificity balance.